1-5 of 5
Hideo Hyodo
Close
Sort by
Journal Articles

Final Results From SENSOR: Switch to Nilotinib After Molecular Suboptimal Response (SoR) to Frontline Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Mitsune Tanimoto, MD PhD, Koichi Miyamura, Toshihiro Miyamoto, MD PhD, Kazuhito Yamamoto, Masafumi Taniwaki, Shinya Kimura, MD, Kazuma Ohyashiki, Tatsuya Kawaguchi, MD PhD, Itaru Matsumura, Tomoko Hata, MD PhD, Hisashi Tsurumi, MD PhD, Shigeki Saito, MD PhD, Masayuki Hino, MD PhD, Seiji Tadokoro, Kuniaki Meguro, MD PhD, Hideo Hyodo, MD, Masahide Yamamoto, MD PhD, Kohmei Kubo, MD PhD, Junichi Tsukada, MD, Midori Kondo, Makoto Aoki, Hikaru Okada, Masamitsu Yanada
Journal: Blood
Blood (2014) 124 (21): 1815.
https://doi.org/10.1182/blood.V124.21.1815.1815
Published: 2014
Journal Articles

Nilotinib Following Molecular Suboptimal Response (SoR) To Imatinib In Japanese Patients (pts) With Chronic Myeloid Leukemia In Chronic Phase (CML-CP): 12 Month Follow-Up From The SENSOR Study

Koichi Miyamura, MD, PhD, Toshihiro Miyamoto, MD, Mineo Kurokawa, MD, PhD, Mitsune Tanimoto, MD, PhD, Kazuhito Yamamoto, M.D., Ph.D., Masafumi Taniwaki, MD, PhD, Shinya Kimura, MD, PhD, Kazuma Ohyashiki, MD, PhD, Tatsuya Kawaguchi, MD, PhD, Itaru Matsumura, MD, PhD, Tomoko Hata, MD, PhD, Hisashi Tsurumi, MD, PhD, Shigeki Saito, MD, PhD, Masayuki Hino, MD, PhD, Seiji Tadokoro, Kuniaki Meguro, M.D., Ph.D., Hideo Hyodo, MD, Masahide Yamamoto, MD, Kohmei Kubo, MD, Junichi Tsukada, Midori Kondo, Taro Amagasaki, PhD, Eiji Kawahara, PhD, Masamitsu Yanada
Journal: Blood
Blood (2013) 122 (21): 2729.
https://doi.org/10.1182/blood.V122.21.2729.2729
Published: 2013
Journal Articles

Expansion of CD8 + /perforin + T-Cell Subset in Patients Predicts Response to Cyclosporin A Therapy in Patients with Erythroid Hypoplasia/Aplasia

Hideaki Nitta, MD, Yuka Harada, MD, Hideo Hyodo, MD, Akiro Kimura, MD, Hironori Harada, MD
Journal: Blood
Blood (2011) 118 (21): 1337.
https://doi.org/10.1182/blood.V118.21.1337.1337
Published: 2011
Journal Articles

Clinical and genetic features of therapy-related myeloid neoplasms after chemotherapy for acute promyelocytic leukemia

Brief Report
Jun Imagawa, Yuka Harada, Takeshi Shimomura, Hideo Tanaka, Yoshiko Okikawa, Hideo Hyodo, Akiro Kimura, Hironori Harada
Journal: Blood
Blood (2010) 116 (26): 6018–6022.
https://doi.org/10.1182/blood-2010-06-289389
Published: 2010
Journal Articles

Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis

Clinical Trials & Observations Brief Report
Keichiro Mihara, Moniruddin Chowdhury, Nanae Nakaju, Sachiko Hidani, Akihiro Ihara, Hideo Hyodo, Shin'ichiro Yasunaga, Yoshihiro Takihara, Akiro Kimura
Journal: Blood
Blood (2006) 107 (1): 305–308.
https://doi.org/10.1182/blood-2005-06-2393
Published: 2006